Adherence to ASCO for Prophylaxis of Acute Chemotherapy- Induced Nausea and Vomiting in Iran
(ندگان)پدیدآور
Ebrahimi, MahbobehMehrzad, ValiollahMoghaddas, Azadehنوع مدرک
TextResearch Articles
زبان مدرک
Englishچکیده
Introduction: Chemotherapy-induced nausea and vomiting (CINV) is one of the scariest chemotherapy-induced adverse effects. We evaluated the adherence to the 2017 American Society of Clinical Oncology (ASCO), the latest guideline recommendations, for the management of acute CINV at our institute. Methods: During a 6-months cross-sectional study on outpatient's cancer patients, we collected data from the prescription documents during temporary hospitalization and compared the results with ASCO guideline recommendations. Results: The most prescribed prophylactic regimens for the management of CINV were combination of aprepitant, granisetron, and dexamethasone and metoclopramide (51.8%). Regarding prescription compatibility in our center with ASCO guideline recommnedations, selection of different regimens for prophylaxis of acute CINV in our institute was compliant in 0 %, 22%, 4%, and 40% of high, moderate, low, and minimal emetogenic potential of chemotherapy regimen groupss, respectively. Conclusion: Although our hospital is a referral and university-affiliated center, adherence to the ASCO guideline recommendations for prophylaxis of CINV was poor.
کلید واژگان
chemotherapy-induced nausea and vomitingAmerican Society of Clinical Oncology
guideline
Prophylaxis
General Oncology
شماره نشریه
6تاریخ نشر
2020-06-011399-03-12
ناشر
West Asia Organization for Cancer Prevention (WAOCP)سازمان پدید آورنده
Department of Clinical Pharmacy, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.Department of Oncology/Hematology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Clinical Pharmacy, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
شاپا
1513-73682476-762X